Details for New Drug Application (NDA): 216066
✉ Email this page to a colleague
The generic ingredient in ERYTHROMYCIN is erythromycin stearate. There are one hundred and three drug master file entries for this compound. Additional details are available on the erythromycin stearate profile page.
Summary for 216066
Tradename: | ERYTHROMYCIN |
Applicant: | Alkem Labs Ltd |
Ingredient: | erythromycin |
Patents: | 0 |
Pharmacology for NDA: 216066
Physiological Effect | Decreased Sebaceous Gland Activity |
Medical Subject Heading (MeSH) Categories for 216066
Suppliers and Packaging for NDA: 216066
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
ERYTHROMYCIN | erythromycin | TABLET;ORAL | 216066 | ANDA | Ascend Laboratories, LLC | 67877-762 | 67877-762-01 | 100 TABLET, FILM COATED in 1 BOTTLE (67877-762-01) |
ERYTHROMYCIN | erythromycin | TABLET;ORAL | 216066 | ANDA | Ascend Laboratories, LLC | 67877-762 | 67877-762-05 | 500 TABLET, FILM COATED in 1 BOTTLE (67877-762-05) |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | 250MG | ||||
Approval Date: | Jul 13, 2022 | TE: | AB | RLD: | No |
Profile for product number 002
Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | 500MG | ||||
Approval Date: | Jul 13, 2022 | TE: | AB | RLD: | No |
Complete Access Available with Subscription